Kevin J. Mcnamara Sells 1,000 Shares of Chemed Co. (NYSE:CHE) Stock

Chemed Co. (NYSE:CHE - Get Free Report) CEO Kevin J. Mcnamara sold 1,000 shares of the firm's stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the sale, the chief executive officer now directly owns 101,679 shares in the company, valued at approximately $62,566,139.07. This trade represents a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Chemed Stock Performance

Shares of NYSE:CHE traded down $21.05 during trading on Friday, reaching $598.17. The stock had a trading volume of 129,318 shares, compared to its average volume of 95,734. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $632.22. The stock has a market cap of $8.76 billion, a PE ratio of 30.23, a PEG ratio of 2.15 and a beta of 0.49. The business has a fifty day moving average price of $580.24 and a 200-day moving average price of $568.04.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date was Monday, February 24th. Chemed's payout ratio is 10.05%.

Remove Ads

Hedge Funds Weigh In On Chemed

A number of institutional investors and hedge funds have recently bought and sold shares of CHE. UMB Bank n.a. lifted its stake in Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock worth $28,000 after purchasing an additional 39 shares in the last quarter. Atala Financial Inc purchased a new position in Chemed during the fourth quarter worth approximately $29,000. CBIZ Investment Advisory Services LLC boosted its stake in Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock worth $30,000 after buying an additional 22 shares during the last quarter. Trust Co. of Vermont purchased a new stake in Chemed in the 4th quarter valued at $34,000. Finally, Tortoise Investment Management LLC grew its holdings in Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock valued at $41,000 after buying an additional 34 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Royal Bank of Canada increased their target price on shares of Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research note on Friday, March 14th. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.